Recruiting Retinitis Pigmentosa Studies in Los Angeles
About Retinitis Pigmentosa Clinical Trials in Los Angeles
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 13 retinitis pigmentosa clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 11,688 participants. Research is being sponsored by Société Internationale d'Urologie, The American Porphyrias Expert Collaborative, Merck Sharp & Dohme LLC and 10 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Los Angeles — FAQ
Are there retinitis pigmentosa clinical trials in Los Angeles?
Yes, there are 13 retinitis pigmentosa clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 13 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated August 28, 2026 from ClinicalTrials.gov